Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223

PURPOSE: Radium-223 is a life-prolonging therapy for castration-resistant prostate cancer (CRPC) patients with symptomatic bone metastases. However, validated biomarkers for response monitoring are lacking. The study aim was to investigate whether early alkaline phosphatase (ALP) dynamics after the...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Doelen, Maarten J., Stockhaus, Agnes, Ma, Yuanjun, Mehra, Niven, Yachnin, Jeffrey, Gerritsen, Winald R., Nilsson, Sten, van Oort, Inge M., Ullén, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426246/
https://www.ncbi.nlm.nih.gov/pubmed/33686456
http://dx.doi.org/10.1007/s00259-021-05283-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426246/
https://www.ncbi.nlm.nih.gov/pubmed/33686456
http://dx.doi.org/10.1007/s00259-021-05283-6

Ejemplares similares